FDA Approves Unknown Drug — ACTAVIS LABS FL INC

On April 12, 2005, the U.S. FDA approved Actavis Labs FL Inc.'s ANDA for a new generic drug, signaling an impending entry of a branded competitor to the market and likely triggering early competitive pricing actions.